Videos

WATCH: Israeli drug doubles survival time for patients with brain tumors

Professor Dror Harats, M.D., CEO of VBL Therapeutics, describes Phase III clinical trials of a cancer treatment in which a virus is injected intravenously and cuts off blood supply to solid tumors, shrinking cancerous growths.

Share
Published by
Eliyahu Tulshinski
Tags: brain tumors cancer treatment Dror Harats solid tumors VBL Therapeutics virus

Recent Posts

  • Arab-Israeli Conflict

US says Lebanese army begins takeover of villages held by IDF

US says Israel-Lebanon agreement enters operational phase in three villages in southern Lebanon.

2 hours ago
  • Jewish Diaspora & Antisemitism

Australian university failed its Jewish students, top officials admit

Administrators of the Australian National University say the school did not live up to its…

5 hours ago
  • Videos

WATCH: ‘Iran is in shambles because they invest in terrorism,’ charges Rubio

Secretary of State Marco Rubio blamed Iran's economic woes on its support for terrorism, using…

5 hours ago
  • Middle East

Trump says Iran has ‘very little left’ after ninth night of US strikes

President Trump says Iran has been 'very badly damaged' after nine nights over US airstrikes.

5 hours ago
  • World News

Fetterman calls Mamdani a ‘clown’ over threat to arrest Netanyahu in New York

Democratic senator blasts New York City's mayor over threats to have Israel's prime minister arrested…

5 hours ago
  • World News

Iran taunts the US: ‘We’re waiting for your ground invasion’

Iranian commentator claims Tehran would welcome a U.S. ground invasion and ultimately emerge victorious.

6 hours ago